...
首页> 外文期刊>International Journal of Basic & Clinical Pharmacology >Utilization pattern of antiepileptic drugs and their adverse effects in tertiary healthcare and teaching hospital
【24h】

Utilization pattern of antiepileptic drugs and their adverse effects in tertiary healthcare and teaching hospital

机译:三级保健和教学医院抗癫痫药的使用方式及其不良反应

获取原文

摘要

Background: Epilepsy is the most common neurological condition with 65 million cases of active epilepsy found worldwide. The incidence is approximately 0.3 - 0.5% in different world populations with a prevalence rate of five to ten per thousand people. The aim of the present study was to evaluate the prescriptions according to WHO/INRUD drug use indicators and to study the adverse effects to antiepileptic drugs (AEDs). Methods: A cross sectional survey based observational study of 1year duration was conducted at tertiary healthcare hospital. Prescription data of patients (n=361) with Epilepsy from Neurology department was analysed using WHO indicators. The demographic data, type of seizures, AEDs prescribed and adverse drug reactions (ADRs) reported by the patients were recorded. Statistical analysis was done using Microsoft excel 2013. Results: A total of 593 AEDs were prescribed to 361 patients. Average number of AEDs prescribed per prescription was 1.65±0.78 (S.D) with only 02% of newer AEDs. Generalized Tonic Clonic (GTC) was the most common seizure with 55.68%. Phenytoin (32%) was commonly prescribed followed by valproate for GTCS. Carbamazepine was commonly prescribed for partial seizures. Out of 15 ADR cases that has been recorded, phenytoin (73%) was associated with most ADRs followed by valproate (20%). 53% patients were on Monotherapy, 31% on dual drug therapy. Conclusions: Older AEDs are still commonly prescribed drugs. Prescription of newer AEDs to be encouraged, as study revealed majority of adverse effects to drugs like phenytoin and valproate. Study concludes the need of creating awareness of reporting of adverse event to AEDs, in treating physician.
机译:背景:癫痫是最常见的神经系统疾病,全世界发现6500万例活动性癫痫。在不同的世界人口中,发病率约为0.3-0.5%,患病率为每千人5至10。本研究的目的是根据WHO / INRUD药物使用指标评估处方,并研究其对抗癫痫药物(AED)的不利影响。方法:在三级保健医院进行了基于横断面调查的1年持续时间观察研究。使用WHO指标分析了神经科神经癫痫患者的处方数据(n = 361)。记录患者的人口统计学数据,癫痫发作类型,开具的AED和不良药物反应(ADR)。使用Microsoft excel 2013进行统计分析。结果:361例患者总共开出593例AED。每个处方开具的AED的平均数量为1.65±0.78(S.D),只有更新的AED的02%。全身性强直性阵挛(GTC)是最常见的癫痫发作,占55.68%。对于GTCS,通常开处方苯妥英(32%),然后再使用丙戊酸盐。卡马西平通常用于部分发作。在已记录的15个ADR病例中,苯妥英钠(73%)与大多数ADR相关,其次是丙戊酸盐(20%)。 53%的患者接受单一疗法,31%的患者接受双重药物疗法。结论:老年AED仍然是常用处方药。由于研究显示对苯妥英和丙戊酸盐等药物的大多数不良反应,应鼓励使用新型AED。研究得出结论,需要在治疗医师时提高对向AED报告不良事件的认识。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号